ExodusPoint Capital Management, LP - CELLDEX THERAPEUTICS INC NEW ownership

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$727
-100.0%
26,434
-80.5%
0.01%
-82.9%
Q1 2021$2,792,000
-6.6%
135,552
-20.5%
0.04%
+41.4%
Q4 2020$2,989,000
+293.8%
170,591
+192.0%
0.03%
+45.0%
Q2 2020$759,00058,4150.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 761,398$41,108,00010.12%
Opaleye Management Inc. 985,000$53,045,0009.91%
VR Adviser, LLC 1,098,174$59,290,0007.62%
ACUTA CAPITAL PARTNERS, LLC 337,500$18,222,0006.43%
TSP Capital Management Group, LLC 271,429$14,654,0005.00%
Ghost Tree Capital, LLC 255,000$13,767,0004.03%
COMMODORE CAPITAL LP 248,207$13,401,0003.53%
RTW INVESTMENTS, LP 3,908,947$211,044,0003.18%
Ikarian Capital, LLC 791,600$42,741,0003.01%
Redmile Group, LLC 3,043,298$164,308,0002.87%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders